1. Home
  2. PLX vs TRAK Comparison

PLX vs TRAK Comparison

Compare PLX & TRAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

HOLD

Current Price

$2.21

Market Cap

174.0M

Sector

Health Care

ML Signal

HOLD

TRAK

ReposiTrak Inc.

HOLD

Current Price

$7.59

Market Cap

144.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLX
TRAK
Founded
1993
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
174.0M
144.0M
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
PLX
TRAK
Price
$2.21
$7.59
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$12.00
N/A
AVG Volume (30 Days)
956.0K
120.3K
Earning Date
05-08-2026
05-14-2026
Dividend Yield
N/A
1.05%
EPS Growth
N/A
20.69
EPS
N/A
0.18
Revenue
$52,744,000.00
$21,007,076.00
Revenue This Year
$36.81
$6.61
Revenue Next Year
$1.77
$10.04
P/E Ratio
N/A
$42.28
Revenue Growth
N/A
4.84
52 Week Low
$1.34
$6.94
52 Week High
$3.19
$23.72

Technical Indicators

Market Signals
Indicator
PLX
TRAK
Relative Strength Index (RSI) 40.45 37.64
Support Level $2.03 $6.94
Resistance Level $2.45 $9.02
Average True Range (ATR) 0.11 0.35
MACD -0.01 0.07
Stochastic Oscillator 20.12 51.91

Price Performance

Historical Comparison
PLX
TRAK

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.

About TRAK ReposiTrak Inc.

ReposiTrak Inc is a software-as-a-service (SaaS) company based in Murray, Utah, specializing in supply chain management solutions for retailers, suppliers, and wholesalers, prominently in the food industry. The company offers three main product suites: ReposiTrak Compliance Management, ReposiTrak Traceability Network, and ReposiTrak Supply Chain Solutions. These platforms help customers comply with food safety regulations, manage supplier compliance documentation, trace products through the supply chain, and optimize supply chain operations. The company derives revenue from five sources: (i) subscription fees, (ii) transaction-based fees, (iii) professional services fees, (iv) license fees, and (v) hosting and maintenance fees.

Share on Social Networks: